← All Stocks

Agilent Technologies, Inc.

A · NYQ
$172.79-2.89%
52W Low: $108.3552W High: $174.77
Current: $172.79  ·  97% of 52-week range
HealthcareDiagnostics & ResearchNYQ
View live charts, options flow & technicals for Agilent Technologies, Inc. → Open Dashboard

Agilent Technologies, Inc. (A) is a healthcare company in the diagnostics & research industry with $7.37B in trailing revenue trading at a 34.1× trailing P/E — analyst consensus: buy.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Key Statistics

Market Cap$48.72B
Revenue (TTM)$7.37B
EPS (TTM)$5.06
EPS (Fwd est.)$6.76
Employees18,200
Trailing P/E34.15
Forward P/E25.57
PEG Ratio1.43
Price / Sales6.61
Price / Book6.62
EV / EBITDA24.57
Beta (5Y)1.24

Analyst Consensus

Consensus
Buy
Analyst Price Target
+1.5% upside
Target: $175.43

Annual Revenue & Net Income

RevenueNet Income
'22
$6.85B
$1.25B
'23
$6.83B
$1.24B
'24
$6.51B
$1.29B
'25
$6.95B
$1.30B

Earnings History


QuarterActual EPSEstimateResult
Aug 2026
$1.62
$1.49Beat (+9.0%)
May 2026
$1.49
$1.41Beat (+5.8%)
Feb 2026
$1.36
$1.37Miss (-0.6%)
Nov 2025
$1.59
$1.58Beat (+0.4%)

Next Earnings Report

Agilent Technologies, Inc. is next expected to report earnings on 25 Nov 2026.

Profitability

53.6%
25.6%
19.5%
Gross
Margin
Operating
Margin
Net
Margin
Revenue Growth (YoY)8.1%
Return on Equity21.0%
Return on Assets8.6%

Balance Sheet

Cash & Equivalents$1.76B
Total Debt$4.15B
Net Position$2.39B (net debt)
Free Cash Flow (TTM)$1.06B
Debt / Equity56.34

Share Ownership

Institutions 95.5%
Insiders 0.2%
Public 4.3%

Dividend

Annual Rate
$1.02
Yield
0.59%
Payout Ratio
20.0%
Ex-Dividend Date
06 Oct 2026
5Y Avg Yield
0.69%

Related Stocks

LLYUNHJNJMRKABBVTMOPFEISRG

Frequently Asked Questions

What does Agilent Technologies, Inc. (A) do?
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass sp…
What is A's market cap?
Agilent Technologies, Inc. has a market capitalization of approximately $48.72B.
What is A's P/E ratio?
Agilent Technologies, Inc. trades at a trailing P/E ratio of 34.1x and a forward P/E of 25.6x, which is above the broad market average of ~25x.
How much revenue does A generate?
Agilent Technologies, Inc. generated $7.37B in trailing 12-month revenue.
What do analysts say about A?
The analyst consensus rating for Agilent Technologies, Inc. is buy, with a mean price target of $175.43. That implies +1.5% upside from the current price.
When does A report earnings?
Agilent Technologies, Inc. is next scheduled to report earnings on 25 Nov 2026.
Does A pay a dividend?
Yes. Agilent Technologies, Inc. pays a dividend with a current yield of 0.59%, at an annual rate of $1.02 per share.

View live charts, options flow, gamma exposure, earnings history, and technical analysis for Agilent Technologies, Inc. on Apsis Markets.

Open Live Dashboard →